MicroRNA 125b inhibition of B cell differentiation in germinal centers
Murali Gururajan1, Christopher L Haga, Sabyasachi Das
1Department of Pathology and Laboratory Medicine, Emory University, 1462 Clifton Road NE, DSB 403, Atlanta, GA 30322, USA.
Abstract:
MicroRNAs 125a and 125b are predicted to be able to bind to the B lymphocyte-induced maturation protein-1 (BLIMP-1) and IFN regulatory protein-4 (IRF-4) transcription factors, which are essential for plasma cell differentiation. A computational survey of the human and mouse genomes revealed that miR-125a and miR-125b are members of a multigene family located in paralogous clusters. The miR-125a cluster on chromosome 19 in humans includes miR-99b and let-7e, whereas the miR-125b cluster on chromosome 21 includes miR-99a and miR-let-7c. Our analysis of the expression profiles for these six miRs during B lineage differentiation indicated that mature miR-125a, miR-125b, miR-99b and let-7e transcripts are preferentially expressed by the actively dividing centroblasts in germinal centers (GC). However, miR-99b and let-7e are not predicted to bind BLIMP-1 or IRF-4 transcripts, and binding to the untranslated region of BLIMP-1 and IRF-4 messenger RNAs could be confirmed only for miR-125b. When the effect of miR-125b over-expression on terminal B cell differentiation was evaluated in an LPS-responsive B cell line, the induction of BLIMP-1 expression and IgM secretion was inhibited in this model system. Furthermore, miR-125b over-expression inhibited the differentiation of primary B cells and compromised the survival of cultured myeloma cells. These findings suggest that miR-125b promotes B lymphocyte diversification in GC by inhibiting premature utilization of essential transcription factors for plasma cell differentiation.
Insights
MicroRNA-125b inhibits plasma cell differentiation by targeting key transcription factors. This microRNA promotes B cell diversification in germinal centers by preventing early use of essential factors.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- MicroRNAs regulate gene expression and are crucial in cellular differentiation.
- Plasma cell differentiation is a critical process in the adaptive immune response.
- B lymphocyte-induced maturation protein-1 (BLIMP-1) and IFN regulatory protein-4 (IRF-4) are essential transcription factors for plasma cell differentiation.
Purpose of the Study:
- To investigate the role of microRNAs 125a and 125b in B cell differentiation.
- To determine the binding targets of miR-125a and miR-125b in the context of plasma cell differentiation.
- To elucidate the functional impact of miR-125b on B cell terminal differentiation and myeloma cell survival.
Main Methods:
- Computational analysis of human and mouse genomes to identify microRNA gene families.
- Expression profiling of six microRNAs during B lineage differentiation.
- In vitro experiments using an LPS-responsive B cell line to assess the effect of miR-125b overexpression.
- Evaluation of miR-125b's impact on primary B cell differentiation and myeloma cell survival.
Main Results:
- miR-125a and miR-125b are part of multigene families located in paralogous clusters.
- Mature miR-125a, miR-125b, miR-99b, and let-7e transcripts are highly expressed in centroblasts within germinal centers.
- Only miR-125b was confirmed to bind the untranslated regions of BLIMP-1 and IRF-4 messenger RNAs.
- Overexpression of miR-125b inhibited BLIMP-1 induction, IgM secretion, primary B cell differentiation, and myeloma cell survival.
Conclusions:
- miR-125b plays a significant role in regulating terminal B cell differentiation.
- miR-125b promotes B lymphocyte diversification in germinal centers by inhibiting premature activation of BLIMP-1 and IRF-4.
- These findings highlight miR-125b as a key regulator in the B cell differentiation pathway and a potential target for myeloma therapy.
Related Concept Videos
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
MicroRNAs
MicroRNAs
Abnormal Proliferation


